Buprenorphine as a stimulus in drug discrimination learning: An assessment of Mu and Kappa receptor activity
- 1 November 1993
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 46 (3) , 593-604
- https://doi.org/10.1016/0091-3057(93)90549-9
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Diprenorphine as a stimulus in drug discrimination learningPharmacology Biochemistry and Behavior, 1992
- Acute opioid administration effects on sensory and motor function in baboonsBehavioural Pharmacology, 1992
- Naloxone as a stimulus in drug discrimination learning: Generalization to other opiate antagonistsPharmacology Biochemistry and Behavior, 1992
- Antagonism of drug discrimination learning within the conditioned taste aversion procedurePharmacology Biochemistry and Behavior, 1992
- Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agentsJournal of Medicinal Chemistry, 1990
- The opioid antagonist, MR2266, specifically decreases saline intake in the mouseNeuropharmacology, 1988
- Buprenorphine has potent kappa opioid receptor antagonist activityNeuropharmacology, 1987
- Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonistsLife Sciences, 1983
- characterization of four types of opioid binding sites in rat brainLife Sciences, 1983
- Bremazocine: A potent, long-acting opiate kappa-agonistLife Sciences, 1980